Larimar Therapeutics, Inc. (LRMR)
4.79
+0.11
(+2.35%)
USD |
NASDAQ |
Apr 02, 16:00
4.775
-0.02
(-0.31%)
After-Hours: 20:00
Larimar Therapeutics EPS Diluted (Quarterly) : -0.7316 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vir Biotechnology, Inc. | -0.3083 |
| Gossamer Bio, Inc. | -0.2085 |
| ImmunityBio, Inc. | -0.0626 |
| BioRestorative Therapies, Inc. | -0.3614 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.50M |
| Total Expenses (Quarterly) | 62.50M |
| Enterprise Value | 364.81M |
| Earnings Yield | -46.09% |
| Normalized Earnings Yield | -46.08 |